The Chemours Co.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About The Chemours Co.
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
/ 
Frequently asked questions
To buy The Chemours Co. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for The Chemours Co. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for The Chemours Co. is CC:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
The Chemours Co. has its primary listing on New York Stock Exchange. You can trade The Chemours Co. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, The Chemours Co. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include The Chemours Co. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like The Chemours Co..